• 1569 Citations
  • 17 h-Index
20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Federica Riva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Interleukin-1 Receptors Medicine & Life Sciences
Innate Immunity Medicine & Life Sciences
Toll-Like Receptors Medicine & Life Sciences
Interleukin-1 Medicine & Life Sciences
Inflammation Medicine & Life Sciences
Mastocytoma Medicine & Life Sciences
Chemokines Medicine & Life Sciences
Gastrointestinal Tract Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1569 Citations
  • 17 h-Index
  • 37 Article
1 Citation (Scopus)

Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment

Obinu, A., Rassu, G., Corona, P., Maestri, M., Riva, F., Miele, D., Giunchedi, P. & Gavini, E., May 1 2019, In : Colloids and Surfaces B: Biointerfaces. 177, p. 520-528 9 p.

Research output: Contribution to journalArticle

Nanoparticles
Tumors
tumors
nanoparticles
Neoplasms

Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin Wounds

Bonferoni, M. C., Sandri, G., Rossi, S., Dellera, E., Invernizzi, A., Boselli, C., Cornaglia, A. I., Del Fante, C., Perotti, C., Vigani, B., Riva, F., Caramella, C. & Ferrari, F., Feb 9 2018, In : Marine Drugs. 16, 2

Research output: Contribution to journalArticle

Sulfadiazine
Chitosan
alpha-Tocopherol
Oleic Acid
Bandages

Illicit drugs and pharmaceuticals in swimming pool waters

Fantuzzi, G., Aggazzotti, G., Righi, E., Predieri, G., Castiglioni, S., Riva, F. & Zuccato, E., Sep 1 2018, In : Science of the Total Environment. 635, p. 956-963 8 p.

Research output: Contribution to journalArticle

Swimming pools
Street Drugs
Drug products
irbesartan
drug
8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Cicchiello, F., Riva, F., Cazzaniga, M. E., Pedani, F., Nicolini, M., Butti, C., Liscia, N., Pogliani, C., Capri, G., Alù, M., Febbraro, A., Petrucelli, L., D'Onofrio, L., De Laurentiis, M., Pellegrini, D., Mentuccia, L., Cocciolone, V., Miraglio, E., Bajardi, E., Dester, M. & 49 others, Paternò, E., Guaitoli, G., Ferrarini, I., Gervasi, E., Licata, L., Benedetto, C., Andreis, D., Bordin, E., Ancona, C., Pizzuti, L., Fotia, V., Berardi, R., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V., Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L. & Torri, V., 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
Cell Dedifferentiation
Multipotent Stem Cells
Regenerative Medicine
stem cells
Stem cells